Standard dosing protocol (monotherapy) Week-by-week titration: Week 1-4: 0.6mg weekly Week 5-8: 1.2mg weekly Week 9-12: 1.8mg weekly Week 13+: 2.4mg weekly (maintenance) Why slow titration: Reduces nausea and GI side effects Allows body to adapt Better long-term adherence Standard in all trials Injection details: Subcutaneous injection Abdomen, thigh, or upper arm Weekly dosing (same day each week) Rotate injection sites Duration of use: Minimum 68 weeks for maximum results Often 12-18 months Maintenance indefinite (to prevent regain) No defined end point Use our peptide calculator , peptide dosing guide , peptide dosage chart , and how to calculate peptide dosages at SeekPeptides
Patients who were obese and took semaglutide were about seven times more likely to develop NAION than those on other medications
Dulaglutide (Trulicity) begins at 0.75 mg once weekly, with potential increases to 1.5 mg, 3 mg, or a maximum of 4.5 mg weekly based on glycemic response
doi:10.1016/j.biortech.2012.10.168 Wang C, Zhang J, Wu H, Li Z, Ye Q (2015) Heterologous gshF gene expression in various vector systems in Escherichia coli for enhanced glutathione production
2012 Oct;34(4):365-70
